ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

NAV NAVCO Pharmaceuticals Inc

0.025
0.005 (25.00%)
01 Nov 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
NAVCO Pharmaceuticals Inc TSXV:NAV TSX Venture Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.005 25.00% 0.025 0.015 0.025 0.025 0.02 0.02 70,480 14:20:41

Pinetree Capital Ltd. Announces Unaudited February 28, 2014 Net Asset Value Per Share of $0.92

14/03/2014 12:00pm

Marketwired Canada


Pinetree Capital Ltd. (TSX:PNP) announces that as at February 28, 2014,
Pinetree's unaudited net asset value per share ("NAV") was $0.92. 


NAV is calculated as at a particular date and is, by its nature, historical, and
may not be reflective of Pinetree's future performance.


Pinetree discloses an unaudited monthly NAV within 15 days after the month-end.
The latest month-end NAV and more details about Pinetree and its investments can
be found on Pinetree's website at www.pinetreecapital.com.


Use of Non-GAAP Financial Measures 

NAV is a non-GAAP (general accepted accounting principles) measure calculated as
the value of total assets less the value of total liabilities divided by the
total number of common shares outstanding as at a specific date. The term NAV
does not have any standardized meaning according to GAAP and therefore may not
be comparable to similar measures presented by other companies. There is no
comparable GAAP measure presented in Pinetree's consolidated financial
statements and thus no applicable quantitative reconciliation for such non-GAAP
financial measure. The Company has calculated NAV consistently for many years
and believes that NAV can provide information useful to its shareholders in
understanding its performance, and may assist in the evaluation of its business
relative to that of its peers.


About Pinetree 

Pinetree Capital Ltd. ("Pinetree") was incorporated under the laws of the
Province of Ontario and its shares are publicly-traded on the Toronto Stock
Exchange ("TSX") under the symbol "PNP". Pinetree is a diversified investment
and merchant banking firm focused on the small cap market. Pinetree's
investments are primarily in the following sectors: Precious Metals, Uranium and
Technology. Pinetree's investment approach is to develop a macro view of a
sector, build a position consistent with the view by identifying micro-cap
opportunities within that sector, and devise an exit strategy designed to
maximize our relative return in light of changing fundamentals and
opportunities. Pinetree is recognized as a value added partner.


FOR FURTHER INFORMATION PLEASE CONTACT: 
Pinetree Capital Ltd.
Sheldon Inwentash, CPA, CA.
Chairman & CEO
416-643-3884


Pinetree Capital Ltd.
Gerry Feldman, CPA, CA
CFO & Vice President, Corporate Development
416-643-3884
feldman@pinetreecapital.com


Pinetree Capital Ltd.
130 King Street West, Suite 2500
Toronto, Ontario, Canada, M5X 2A2
www.pinetreecapital.com


Investor Relations: Pinetree Capital Ltd.
Richard Patricio, LL.B.
Vice President, Legal and Corporate Affairs
416-941-9600
ir@pinetreecapital.com

1 Year NAVCO Pharmaceuticals Chart

1 Year NAVCO Pharmaceuticals Chart

1 Month NAVCO Pharmaceuticals Chart

1 Month NAVCO Pharmaceuticals Chart

Your Recent History

Delayed Upgrade Clock